New attack on Tough-to-Treat colon cancer cells
NCT ID NCT05843188
Summary
This study tests whether adding hydroxychloroquine (an anti-malaria drug) to standard chemotherapy helps control metastatic colorectal cancer in patients whose tumors show signs of drug resistance. About 155 patients will be screened, with up to 31 receiving the full four-drug combination. Treatment continues until the cancer worsens or side effects become too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
-
Sunnybrook Odette Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
Conditions
Explore the condition pages connected to this study.